Senator Elizabeth Warren has formally questioned JPMorgan CEO Jamie Dimon about whether he lobbied the UK government on the advice of the late Jeffrey Epstein, according to a Financial Times report. The inquiry stems from documents released by the Department of Justice earlier this year.
Shares of Marvell Technology fell sharply on Monday, caught in a wider semiconductor sector downturn driven by concerns over slowing AI-related growth and rising interest rate expectations. The decline was compounded by the end of technical buying support and recent insider selling.
Israel's benchmark TA 35 index ended Monday's session nearly unchanged, rising just 0.07% as strength in specific sectors masked weakness across the broader Tel Aviv Stock Exchange.
Jefferies upgraded Deckers Outdoor to Buy from Hold, arguing that investor concerns over a growth slowdown in the HOKA brand are overblown and already reflected in the stock's compressed valuation.
Recent SEC filings show significant insider buying at cybersecurity firm Netskope and food producer Mission Produce, while major shareholders and executives at Dell Technologies, Okta, and Broadcom sold millions in stock.
The clinical-stage company's stock gained after announcing it will meet with the U.S. FDA to discuss a registrational pathway for its metastatic colorectal cancer therapy, pelareorep.
Shares of the pharmaceutical company gained in pre-market trading after BMO Capital cited the continued revenue durability of its immunology drug Skyrizi, despite new competition.
Benchmark has initiated coverage on Walt Disney with a 'Buy' rating and a $115 price target, citing the company's powerful Experiences division and improving streaming profitability as key drivers for future growth.
French President Emmanuel Macron has criticized individual national defense policies in Europe, urging greater collaboration as countries increase military spending following the collapse of a key Franco-German fighter jet project.
